Today they announce some corporation agreement with PFE, they will let PFE use their device in clinical trials of liver disease. This might get BreathID some recognition. An important step IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.